Sameep Sonvane, Professor, Mahesh Birajdar, Kranti Satpute, Prakash Shivnachari,
Dayanand College of Pharmacy, Latur, Maharashtra, India.
Omprakash Bhusnure,
Channabasweshwar Pharmacy College, Latur, Maharashtra, India.
Nitin Lonikar,
Latur College of Pharmacy, Hasegaon, Latur, Maharashtra, India.
“DESIGN AND DEVELOPMENT OF SOME NOVEL HETEROCYCLIC COMPOUNDS TARGETED FOR NAV1.7”
Authors
Abstract
Pain is generally known as a disruptive sentiment which is results of forceful and damaging
stimuli. Neuropathic pains (NP) are regularly associated with the chronic form which is
result of the injury in the somatosensory nerves. 8-10% of the general population is found to
be affected by neuropathic pain and it is normally associated with the sever clinical condition
as more than 60 % of cases are associated with diabetic, cancer and other several injuries.
To overcome of these need to synthesis novel heterocyclic compounds.1,3, 4-Oxadiazole ring
has a crucial important in heterocyclic chemistry and have extensive utilization in screening
for various biological activities. 1, 3, 4-Oxadiazole and Indole containing compounds have
been gained considerable attention in pharmaceutical field due to their remarkable
bioactivities. 6 different heterocyclic derivatives from Indole substituted Oxadiazole class
were synthesized Molecules that are synthesized are characterized via by IR, Mass, C13 and
H1 NMR spectral analysis. All the synthesized derivatives were found to be networking with
Nav 1.7 which indicated further biological optimization of these compounds may lead to
strong Nav 1.7inhibitors. Neuropathic pain activity of synthesized compound carried out by
streptozocine (STZ) induced diabetic pain model.